International medtech competition review
This article was originally published in The Gray Sheet
The International Trade Commission, at the request of the House Ways & Means Committee, has launched a general fact-finding investigation regarding the competitive conditions affecting U.S. sales and trade of medical devices in principal foreign markets, according to an April 3 release. Japan is highlighted as a market of particular interest, following a hearing held by the committee in September in which the country's regulatory policies on medical technology were criticized as a "non-tariff barrier" (1"The Gray Sheet" Oct. 3, 2005, p. 11). The ITC will examine the most recent five-year period for which data are available, and must provide a report to the committee by March 9, 2007. In addition, the commission will hold a public hearing on the subject July 11...
You may also be interested in...
Japan's regulatory and reimbursement systems came under fire this week from lawmakers on Capitol Hill and attendees of AdvaMed's international conference in Arlington, Va
Hanmi showcases at JPM its contract production capabilities for COVID-19 vaccines as South Korea prepares to bring in candidates from several global developers, while LG Chem highlights progress across multiple pipeline projects.
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker